G A van Seventer
University of Chicago
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by G A van Seventer.
Graefes Archive for Clinical and Experimental Ophthalmology | 1999
Lili Farrokh-Siar; Kourous A. Rezai; Roshanak Tolouei Semnani; Samir C. Patel; Jt Ernest; G A van Seventer
Abstract · Background: The suppressive effect of human fetal retinal pigment epithelium (HFRPE) on the activation of human CD4+ and CD8+ T-cells was evaluated in vitro. · Methods: Pure populations of CD4+ and CD8+ T-cells were isolated from human peripheral blood-derived buffy coats by negative immunomagnetic selection. The purity of the cells was examined by flow cytometry using anti-CD3-FITC, anti-CD4-FITC, anti-CD8-PE, and anti-CD20-PE mAbs. HFRPE cells were isolated from fetal eyes and pure cultures were obtained. The effect of normal or IFN-γ-activated HFRPE cells at early (P3) or late (P6) passages on the activation of CD4+ and CD8+ T-cells was assessed in two different T-cell activation assays. In both activation models anti-CD3 mAb (OKT3) provided the antigen-specific signal. The secondary signal for the activation of CD4+ and CD8+ T-cells was provided with anti-CD18 mAb (TS1/18) and anti-CD28 mAb (9.3) in the first and the second assay respectively. Cross-linking of these soluble mAbs was performed with sheep-anti-mouse IgG-coated latex beads. The T-cell activation was determined by cell proliferation measured by [3H]thymidine incorporation. In each activation assay T-cells were incubated with HFRPE cells in a ratio of T-cells to HFRPE of 1:1 or 1:4. · Results: CD4+ and CD8+ T-cells were activated by cross-linking CD3 and CD18 in the first assay (CD3/CD18) and CD3 and CD28 in the second assay (CD3/CD28). In both assays HFRPE inhibited the activation of CD4+ and CD8+ T-cells. IFN-γ-activated HFRPE cells totally suppressed the T-cell activation at a 1:1 ratio. This suppressive effect was weaker at lower cell ratios. Some donor variation was observed in the inhibition at the lower cell ratios, especially for the inhibition of CD8+ T-cell activation with anti-CD3/CD18. The passaging of HFRPE cells did not alter their suppressive effect on CD4+ and CD8+ T-cells. · Conclusions: HFRPE cells suppressed the activation of both CD4+ and CD8+ T-cells in vitro. These findings suggest that RPE-induced immune suppression may play a significant role in maintaining immune privilege in the subretinal space.
Archive | 1989
G A van Seventer; R. A. W. Van Lier; H Spits; Karel C. Kuijpers; Cornelis J. M. Melief
The CD8 (T8) antigen is thought to function as an additional stabilizer of the interaction of the cytotoxic T lymphocyte (CTL) with the target cell by binding to monomorphic determinants on the HLA class I molecules. Recent evidence, however, indicates that the CD8 molecules do not merely serve as passive adhesion structures, but also exert regulating effects on T-cell activity (1). Therefore, we decided to reinvestigate the role of the CD8 antigen in CD8+ HLA class I and class II allospecific human CTL clones.
Journal of Immunology | 1990
G A van Seventer; Yoji Shimizu; Kevin J. Horgan; Stephen Shaw
Journal of Immunology | 1990
Yoji Shimizu; G A van Seventer; Kevin J. Horgan; Stephen Shaw
Journal of Experimental Medicine | 1992
Yoshiya Tanaka; Steven M. Albelda; Kevin J. Horgan; G A van Seventer; Yoji Shimizu; Walter Newman; J Hallam; Peter J. Newman; Clayton A. Buck; Stephen Shaw
Journal of Immunology | 1989
Yoji Shimizu; G A van Seventer; R Siraganian; L Wahl; Stephen Shaw
Journal of Immunology | 1994
Gerrit Koopman; Robert M. J. Keehnen; Ernst Lindhout; Walter Newman; Yoji Shimizu; G A van Seventer; C.H. de Groot; Steven T. Pals
Science | 1990
D S A Webb; Yoji Shimizu; G A van Seventer; Stephen Shaw; T L Gerrard
Journal of Experimental Medicine | 1992
Yoji Shimizu; G A van Seventer; Elizabeth Ennis; Walter Newman; Kevin J. Horgan; Stephen Shaw
Journal of Immunology | 1989
S K Lo; G A van Seventer; S M Levin; S D Wright